MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Moving beyond trial and error: a strategy for anatomically informed contact selection in subthalamic deep brain stimulation for Parkinson’s disease.

    GA. Brandt, V. Stopic, C. Hennen, JN. Strelow, JN. Petry-Schmelzer, JC. Baldermann, MT. Barbe, V. Visser-Vandevalle, TA. Dembek (Cologne, Germany)

  • MR-guided focused ultrasound pallidothalamic tractotomy in non-tremor dominant (akinetic-rigid) Parkinson’s disease treatment

    R. Galimova, G. Akhmadeeva, D. Nabiullina, F. Kashapov, O. Kachemaeva, YU. Sidorova, D. Teregulova, N. Mukhamadeeva, D. Krekotin, I. Buzaev, SH. Safin, S. Illarioshkin (Ufa, Russian Federation)

  • MR-morphological changes in PD patients with heterozygous GBA mutation

    J. Reimer, K. Faust, GH. Schneider, AA. Kühn, P. Krause (Berlin, Germany)

  • MRgFUS thalamotomy in dystonic and essential tremor: a prospective study with one year follow up

    N. Golfrè Andreasi, A. Braccia, F. Ghielmetti, LM. Romito, R. Cilia, AE. Elia, G. Devigili, G. Messina, V. Levi, S. Rinaldo, M. Corradi, G. Barbiera, F. Paio, M. Stanziano, S. Prioni, P. Amami, M. Fusarpoli, SHM. Piacentini, MG. Bruzzone, M. Grisoli, EFM. Ciceri, R. Eleopra (Milano, Italy)

  • MRI morphometry and regional hypometabolism in the clinical predominance-types of Progressive Supranuclear Palsy

    H. Chovatiya, K. Pillai, R. Kamble, S. Santhamma, P. Rajeswari, M. Chacko, A. Kishore (Kochi, India)

  • Multi-stakeholder focus group study to develop recommendations of ways to improve treatment burden and capacity in Parkinson’s disease

    QY. Tan, S. Fraser, H. Roberts, K. Ibrahim (Southampton, United Kingdom)

  • Multicenter, randomized, placebo-controlled, double-blind, parallel-group proof-of-concept study of lixisenatide in patients with early Parkinson’s disease (PD): the LIXIPARK trial (NCT03439943)

    WG. Meissner, P. Remy, C. Giordana, D. Maltete, P. Damier, JL. Houeto, C. Geny, L. Hopes, F. Durif, G. Defer, C. Tranchant, JC. Corvol, N. Carriere, JP. Azulay, S. Drapier, P. Krystkowiak, C. Thalamas, A. Benard, O. Rascol, N. Ns-Park/fcrin (Bordeaux, France)

  • Multimodal imaging analysis of autosomal recessive Parkinson’s disease.

    B. Soydas-Turan, G. Yalcin-Cakmakli, E. Yetim, B. Volkan-Salanci, E. Lay-Ergun, K. Karli-Oguz, B. Elibol (Ankara, Turkey)

  • Multimodal neuroimaging of Parkinson’s disease with diffusion tensor imaging (DTI) and dopamine transporter (DAT) positron emission tomography

    P. Honhar, S. Tinaz, M. Dias, R. Comley, S. Finnema, R. Carson, D. Scheinost, D. Matuskey (New Haven, USA)

  • Multimodal neuroimaging to probe brain networks in Cervical Dystonia.

    SR. Bostan, R. King, C. Fearon, M. Hutchinson, R. Reilly (Dublin, Ireland)

  • « Previous Page
  • 1
  • …
  • 111
  • 112
  • 113
  • 114
  • 115
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley